These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34748676)

  • 1. Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019.
    McCluskey G; Duddy W; Haffey S; Morrison K; Donaghy C; Duguez S
    Eur J Neurol; 2022 Mar; 29(3):707-714. PubMed ID: 34748676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology.
    Donaghy C; Clarke J; Patterson C; Kee F; Hardiman O; Patterson V
    Amyotroph Lateral Scler; 2010 Aug; 11(4):374-8. PubMed ID: 20550486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and prevalence of motor neurone disease in South Australia.
    Luker J; Woodman R; Schultz D
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):195-202. PubMed ID: 35934980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An all-Ireland epidemiological study of MND, 2004-2005.
    Donaghy C; O'Toole O; Sheehan C; Kee F; Hardiman O; Patterson V
    Eur J Neurol; 2009 Jan; 16(1):148-53. PubMed ID: 19087159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of motor neurone disease in two counties in the southwest of England.
    Imam I; Ball S; Wright D; Hanemann CO; Zajicek J
    J Neurol; 2010 Jun; 257(6):977-81. PubMed ID: 20094727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing epidemiology of motor neurone disease in Scotland.
    Leighton DJ; Newton J; Stephenson LJ; Colville S; Davenport R; Gorrie G; Morrison I; Swingler R; Chandran S; Pal S;
    J Neurol; 2019 Apr; 266(4):817-825. PubMed ID: 30805795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characteristics of motor neuron disease in Chinese patients.
    Cui F; Liu M; Chen Y; Huang X; Cui L; Fan D; Pu C; Lu J; Zhou D; Zhang C; Yan C; Li C; Ding X; Liu Y; Li X; Jiang Y; Zhang J; Shang H; Yao X; Ding Y; Niu Q; Wang L
    Acta Neurol Scand; 2014 Aug; 130(2):111-7. PubMed ID: 24689740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.
    Sørensen TT; Horváth-Puhó E; Nørgaard M; Ehrenstein V; Henderson VW
    BMJ Open; 2019 Jul; 9(7):e030015. PubMed ID: 31278107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over.
    Forbes RB; Colville S; Swingler RJ;
    Age Ageing; 2004 Mar; 33(2):131-4. PubMed ID: 14960427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis in Nordland county, Norway, 2000-2015: prevalence, incidence, and clinical features.
    Benjaminsen E; Alstadhaug KB; Gulsvik M; Baloch FK; Odeh F
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):522-527. PubMed ID: 30265157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of multimorbidity and its impact on survival in people with motor neuron disease.
    Glasmacher SA; Kearns PKA; Larraz J; Stirland L; Mehta AR; Newton J; Weir CJ; Chandran S; Pal S;
    Eur J Neurol; 2021 Aug; 28(8):2756-2765. PubMed ID: 34036680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype characterisation of long survivors with motor neuron disease in Scotland.
    Leighton DJ; Ansari M; Newton J; Parry D; Cleary E; Colville S; Stephenson L; Larraz J; Johnson M; Beswick E; Wong M; Gregory J; Carod Artal J; Davenport R; Duncan C; Morrison I; Smith C; Swingler R; Deary IJ; Porteous M; Aitman TJ; Chandran S; Gorrie GH; Pal S; ;
    J Neurol; 2023 Mar; 270(3):1702-1712. PubMed ID: 36515702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996-2021.
    McFarlane R; Peelo C; Galvin M; Heverin M; Hardiman O
    Neurology; 2023 Nov; 101(19):e1905-e1912. PubMed ID: 37748881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative care for patients with motor neurone disease and their bereaved carers: a qualitative study.
    Mc Veigh C; Donaghy C; Mc Laughlin B; Dick A; Kaur K; Mc Conville J; Watson M
    BMC Palliat Care; 2019 Apr; 18(1):39. PubMed ID: 31027498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor Neuron Disease Register for England, Wales and Northern Ireland-an analysis of incidence in England.
    Opie-Martin S; Ossher L; Bredin A; Kulka A; Pearce N; Talbot K; Al-Chalabi A
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):86-93. PubMed ID: 32940088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of motor nueron disease in Scotland.
    Forbes RB; Colville S; Parratt J; Swingler RJ
    J Neurol; 2007 Jul; 254(7):866-9. PubMed ID: 17420925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of amyotrophic lateral sclerosis.
    Kurtzke JF
    Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of incidence of motor neuron disease in England 1998-2019: use of three linked datasets.
    Burchardt JM; Mei XW; Ranger T; McDermott CJ; Radunovic A; Coupland C; Hippisley-Cox J
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):363-371. PubMed ID: 35103515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.